Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

AstraZeneca AZ

AZ’s Brilinta disappoints in stroke trial

Antiplatelet drug fails to demonstrate significant benefit in ischaemic stroke

- PMLiVE

IQWiG unimpressed with Cosentyx in two new indications

Concludes Novartis drug has no added benefit in ankylosing spondylitis or psoriatic arthritis

- PMLiVE

Applying real-world evidence to orphan drugs

How to prove pharma’s innovative treatments really can bring about positive outcomes

A rough guide to… advisory boards

Our intrepid writers take us on a journey through advisory boards and show that pre-trip planning is the pathway to perfection

- PMLiVE

Micreos appoints chief medical officer

Dr Johan Frieling brings experience from Bayer and Genzyme

- PMLiVE

Valeant begins search for new CEO

Michael Pearson will continue in the role until his successor is appointed

There’s never a dull moment at Lucid Group

Andrea Hamlin, Angela Tye-Galichet, Emma Herring and Ify Onyeaso were all treated to a fabulous lunch with the Lucid Co-Founders, Dennis O’Brien and Jan Steele in celebration of their 5...

Lucid Group Communications Limited

Lucid Group support local charity event

Lucid Group donated 75 Easter chocolate bunnies to a group of local school children organising an Easter Egg Hunt who were raising funds for Médecins Sans Frontières. The egg hunt...

Lucid Group Communications Limited

- PMLiVE

Apple creates open source personal health app software

Will release CareKit framework later in the Spring 

- PMLiVE

Amgen and UCB’s romosozumab hits goals in male osteoporosis

Firms will discuss data with regulators before planning a new male licence application

Novartis building

NICE backs Novartis’ Entresto for heart failure

But approves narrower indication than has been authorised by Scotland's SMC

- PMLiVE

Nicki Muir moves from LEC Healthcare to The Purple Agency

She joins as account director of its healthcare team

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links